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Cytochromes P450 (CYP450) are a superfamily of
enzymes, involved in metabolism of a large number of
xenobiotic compounds. CYP450 are involved in degrada-
tion of a large amount of drugs, currently present on the
market. The promiscuity with respect to substrates
makes the CYP450 enzymes prone to inhibition by a
large amount of drugs, which gives way to clinically sig-
nificant drug-drug interactions.
In this work different machine learning methods were
applied to classify the inhibitors/noninhibitors of human
CYP450 1A2. The structures and the active/inactive
classification concerning CYP1A2 inhibition were taken
from PubChem BioAssay database. This assay uses
human CYP1A2 to measure the demethylation of luci-
ferin 6’ methyl ether (Luciferin-ME; Promega-Glo) to
luciferin.
The tested methods include k nearest neighbors
(kNN), decision tree, random forest, support vector
machine (SVM) and associative neural networks
(ASNN). The descriptors used were those from the Dra-
gon software, the fragment descriptors and the E-state
indices.
The training and test sets were handled separately to
avoid different possibilities of overfitting - including
overfitting by descriptor selection. Different applicability
domain (AD) approaches were used to estimate the con-
fidence of classification.
As a result the models managed to correctly classify
80% of the test set instances. The accuracy of classifica-
tion was found to be up to 95%, if only 30% most confi-
dent predictions were taken into account. The model
was also applied to an external test set of 187 molecules,
collected from literature and measured using a different
etalon reaction. For this set accuracy of 78% was
achieved on the 30% most confident predictions.
All the developed models are fast enough to be used
for virtual screening of CYP1A2 inhibitors and noninhi-
bitors. The developed models are publicly available
on-line at the http://qspr.eu web site.
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